Follicular Non-hodgkin Lymphoma

• CLINICAL_TRIALS trial_result · 2022-06-21
  Clinical Trial Update: Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular Lymphoma [Phase 3]

  Phase 3 clinical trial assessing a response-adapted strategy in follicular non-Hodgkin's lymphoma has completed.

• CLINICAL_TRIALS trial_result · 2020-09-09
  Clinical Trial Update: Study of Intratumoral G100 With Or Without Pembrolizumab or Rituximab In Participants With Follicular Non-Hodgkin's Lymphoma (MK-3475-174/IMDZ-G142) [Phase 1, Phase 2]

  Clinical trial update for intratumoral G100 with or without pembrolizumab or rituximab in follicular non-Hodgkin's lymphoma; trial terminate…

• CLINICAL_TRIALS trial_result · 2019-05-15
  Clinical Trial Update: Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma [Phase 3]

  Phase 3 clinical trial evaluating rituximab in treating follicular non-Hodgkin's lymphoma has completed.

• CLINICAL_TRIALS trial_result · 2018-11-15
  Clinical Trial Update: S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma [Phase 2]

  Phase 2 trial update for S0801 evaluating iodine-131 tositumomab, rituximab, and combination chemotherapy in previously untreated follicular…

• CLINICAL_TRIALS trial_result · 2018-07-26
  Clinical Trial Update: Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma [Phase 2]

  Phase 2 trial evaluating ofatumumab in previously untreated follicular non-Hodgkin lymphoma has completed with results posted.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2016-11-04
  Clinical Trial Update: A Study of Obinutuzumab in Combination With Chemotherapy in Participants With CD20+ B-Cell Follicular Non-Hodgkin's Lymphoma [Phase 1]

  A completed Phase 1 study evaluating obinutuzumab in combination with chemotherapy in patients with CD20+ follicular non-Hodgkin lymphoma.

• CLINICAL_TRIALS trial_result · 2015-08-05
  Clinical Trial Update: A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma [Phase 3]

  Phase 3 trial comparing subcutaneous versus intravenous rituximab in follicular non-Hodgkin's lymphoma completed with posted results.

• CLINICAL_TRIALS trial_result · 2014-07-24
  Clinical Trial Update: Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma [Phase 2]

  Phase 2 trial of epratuzumab in combination with rituximab for previously untreated follicular non-Hodgkin lymphoma completed, with results …

• CLINICAL_TRIALS trial_result · 2014-02-20
  Clinical Trial Update: Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma [Phase 2]

  Phase 2 clinical trial evaluating lenalidomide plus rituximab in previously untreated follicular non-Hodgkin lymphoma shows results posted, …

• CLINICAL_TRIALS trial_result · 2012-04-23
  Clinical Trial Update: A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma [Phase 1]

  A Phase 1 study evaluating pharmacokinetics, whole-body/organ dosimetry, and biodistribution of fission-derived iodine-131 tositumomab (BEXX…